These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26843068)

  • 1. Viral load monitoring and antiretroviral treatment outcomes in a pediatric HIV cohort in Ghana.
    Kukoyi O; Renner L; Powell J; Barry O; Prin M; Kusah J; Cong X; Paintsil E
    BMC Infect Dis; 2016 Feb; 16():58. PubMed ID: 26843068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of first-line antiretroviral therapy and correlates of longitudinal changes in CD4 and viral load among HIV-infected children in Ghana.
    Barry O; Powell J; Renner L; Bonney EY; Prin M; Ampofo W; Kusah J; Goka B; Sagoe KW; Shabanova V; Paintsil E
    BMC Infect Dis; 2013 Oct; 13():476. PubMed ID: 24119088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy-Years Viremia and Risk of Virological Failure in Long-Term-Treated HIV Patients.
    Falasca F; De Vito C; Mazzuti L; di Carlo D; Celani L; Fimiani C; dʼEttorre G; Mezzaroma I; Antonelli G; Turriziani O
    J Acquir Immune Defic Syndr; 2019 Apr; 80(4):423-428. PubMed ID: 30531307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of viremia copy-years in people with HIV/AIDS after initiation of antiretroviral therapy.
    Wright ST; Hoy J; Mulhall B; Oʼconnor CC; Petoumenos K; Read T; Smith D; Woolley I; Boyd MA
    J Acquir Immune Defic Syndr; 2014 May; 66(1):55-64. PubMed ID: 24463783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viremia copy-years as a predictive marker of all-cause mortality in HIV-1-infected patients initiating a protease inhibitor-containing antiretroviral treatment.
    Chirouze C; Journot V; Le Moing V; Raffi F; Piroth L; Reigadas S; Cassuto JP; Chêne G; Leport C; Hoen B;
    J Acquir Immune Defic Syndr; 2015 Feb; 68(2):204-8. PubMed ID: 25590273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study.
    Quiros-Roldan E; Raffetti E; Castelli F; Focà E; Castelnuovo F; Di Pietro M; Gagliardini R; Gori A; Saracino A; Fornabaio C; Sighinolfi L; Di Filippo E; Maggiolo F; Donato F
    J Antimicrob Chemother; 2016 Dec; 71(12):3519-3527. PubMed ID: 27543658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viremia copy-years and mortality among combination antiretroviral therapy-initiating HIV-positive individuals: how much viral load history is enough?
    Wang R; Haberlen SA; Palella FJ; Mugavero MJ; Margolick JB; Macatangay BJC; Martínez-Maza O; Jacobson LP; Abraham AG
    AIDS; 2018 Nov; 32(17):2547-2556. PubMed ID: 30379686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Viremia During Pregnancy and Neurodevelopment of HIV-Exposed Uninfected Children in the Context of Universal Antiretroviral Therapy and Breastfeeding: A Prospective Study.
    le Roux SM; Donald KA; Kroon M; Phillips TK; Lesosky M; Esterhuyse L; Zerbe A; Brittain K; Abrams EJ; Myer L
    Pediatr Infect Dis J; 2019 Jan; 38(1):70-75. PubMed ID: 30234792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study.
    Salazar-Vizcaya L; Keiser O; Karl Technau ; Davies MA; Haas AD; Blaser N; Cox V; Eley B; Rabie H; Moultrie H; Giddy J; Wood R; Egger M; Estill J
    AIDS; 2014 Oct; 28(16):2451-60. PubMed ID: 25392857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative HIV Viremia Copy-Years and Hypertension in People Living with HIV.
    Xu Y; Chen X; Wijayabahu A; Zhou Z; Yu B; Spencer EC; Cook RL
    Curr HIV Res; 2020; 18(3):143-153. PubMed ID: 32003696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy.
    Suaysod R; Ngo-Giang-Huong N; Salvadori N; Cressey TR; Kanjanavanit S; Techakunakorn P; Krikajornkitti S; Srirojana S; Laomanit L; Chalermpantmetagul S; Lallemant M; Le Cœur S; McIntosh K; Traisathit P; Jourdain G
    Clin Infect Dis; 2015 Jul; 61(1):95-101. PubMed ID: 25838288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective long-term outcomes of a cohort of Ugandan children with laboratory monitoring during antiretroviral therapy.
    Kekitiinwa A; Asiimwe AR; Kasirye P; Korutaro V; Kitaka S; Maganda A; Madalon M; Graziano FM
    Pediatr Infect Dis J; 2012 Aug; 31(8):e117-25. PubMed ID: 22581223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.
    Kebe K; Thiam M; Diagne Gueye NR; Diop H; Dia A; Signate Sy H; Charpentier C; Belec L; Mboup S; Toure Kane C
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):242-9. PubMed ID: 22860571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic malaria parasitaemia and virological non-suppression among children living with HIV in a low transmission area in Accra, Ghana: a cross-sectional study.
    Afrane AKA; Alhassan Y; Amoah LE; Nyarko MY; Addo-Lartey A; Paintsil E; Torpey K
    BMC Infect Dis; 2024 Oct; 24(1):1144. PubMed ID: 39394078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.
    Archampong TN; Lartey M; Sagoe KW; Obo-Akwa A; Kenu E; Gillani FS; Yang H; Boamah I; Flanigan T; Kwara A
    BMC Infect Dis; 2016 Jan; 16():14. PubMed ID: 26759172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study.
    Myer L; Dunning L; Lesosky M; Hsiao NY; Phillips T; Petro G; Zerbe A; McIntyre JA; Abrams EJ
    Clin Infect Dis; 2017 Feb; 64(4):422-427. PubMed ID: 27927852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
    Myer L; Phillips TK; McIntyre JA; Hsiao NY; Petro G; Zerbe A; Ramjith J; Bekker LG; Abrams EJ
    HIV Med; 2017 Feb; 18(2):80-88. PubMed ID: 27353189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.
    Aghokeng AF; Monleau M; Eymard-Duvernay S; Dagnra A; Kania D; Ngo-Giang-Huong N; Toni TD; Touré-Kane C; Truong LX; Delaporte E; Chaix ML; Peeters M; Ayouba A;
    Clin Infect Dis; 2014 Jan; 58(1):99-109. PubMed ID: 24076968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.